Education

How Is 7-OH Made? From Kratom Leaf to Concentrate

7-hydroxymitragynine (7-OH) is primarily produced in the liver from mitragynine, a major alkaloid in the kratom plant, or can be extracted and concentrated from kratom leaves. This process involves several steps, whether occurring naturally within the body or through laboratory and manufacturing methods. Understanding its origin is key to comprehending its effects and potential risks.

Medically reviewed · Evidence-basedBy Benjamin Zohar, NCACIP · Reviewed by Brandon McNally, RNPublished · Updated · Last reviewed

What is 7-Hydroxymitragynine (7-OH)?

7-hydroxymitragynine (7-OH) is a potent alkaloid found in the kratom plant (Mitragyna speciosa). While present in the plant itself, it typically occurs in very small quantities compared to other alkaloids like mitragynine. Research suggests that 7-OH is responsible for many of the opioid-like effects associated with kratom.

Due to its potency, 7-OH has become a focus of both scientific study and commercial product development. Its presence and concentration are significant factors in the overall impact of kratom and kratom-derived products on the human body.

Natural Production in the Body After Kratom Consumption

When kratom is consumed, the primary alkaloid, mitragynine, undergoes metabolism in the liver. This metabolic process, primarily involving cytochrome P450 enzymes, converts a portion of the mitragynine into 7-hydroxymitragynine. This means that even if a kratom product has a low natural concentration of 7-OH, the body can still produce it after ingestion.

The amount of 7-OH produced can vary depending on individual metabolism, the amount of mitragynine consumed, and other factors. This metabolic conversion is a critical aspect of understanding how kratom exerts its effects.

Extraction from Kratom Leaves for Concentrated Products

Beyond natural bodily conversion, 7-OH can also be directly extracted and isolated from kratom leaves. This process typically occurs in laboratory or manufacturing settings. The goal of extraction is to obtain a more concentrated form of 7-OH, often for use in specialized products.

The extraction process involves several steps to separate the desired alkaloids from the plant material. These methods can vary in complexity and efficiency, influencing the purity and concentration of the final extract.

  • Grinding dried kratom leaves into a fine powder.
  • Soaking the powder in solvents (e.g., ethanol, methanol, or water) to dissolve the alkaloids.
  • Filtering the plant material to separate the liquid containing the dissolved alkaloids.
  • Evaporating the solvent to obtain a crude alkaloid extract.
  • Further purification steps, such as acid-base extraction or chromatography, to isolate and concentrate 7-OH specifically.

Concentration and Formulation into Products

Once extracted, 7-OH can be further concentrated and formulated into various products. These products are often marketed as having enhanced potency compared to raw kratom leaf. The concentration of 7-OH in these products can be significantly higher than what is naturally found in the plant.

Consumers should be aware that products with high concentrations of 7-OH may carry increased risks due to their enhanced potency. These products often come in forms like extracts, tinctures, or specialized capsules.

Understanding the Risks and Seeking Help

The increased potency of 7-OH, whether produced metabolically or consumed in concentrated forms, raises significant concerns regarding its potential for dependence and addiction. Higher concentrations may lead to more intense effects and a greater risk of developing tolerance and withdrawal symptoms.

If you or someone you know is struggling with kratom or 7-OH use, please know that help is available. Addiction is a treatable condition, and seeking professional medical or therapeutic support is a courageous and essential step toward recovery. Resources are available to help you navigate this journey safely and effectively.

Frequently Asked Questions

Author

Benjamin Zohar, NCACIP

Nationally Certified Advanced Clinical Intervention Professional (NCACIP) · NAADAC Member · ISSUP Network Moderator

Benjamin Zohar is an addiction recovery professional, NAADAC member, and founder of Intervention New York (Intervention NY). A Nationally Certified Advanced Clinical Intervention Professional (NCACIP), he operates a statewide network of treatment navigation, placement, and crisis intervention services across New York, including the Hudson Valley Addiction Treatment Center, Long Island Addiction Treatment Resources, and Every1 Center. He specializes in clinical placement, structured family and executive interventions, and benefits navigation. As an ISSUP Network Moderator, he leads the Integrated Recovery & Intervention Education Network (IRIEN) and authors practical guides and peer-reviewed articles on emerging substance use threats. He also maintains active advocacy membership with the National Alliance on Mental Illness (NAMI).

Medically Reviewed By

Brandon McNally, RN

Registered Nurse (RN) · Medical Reviewer

Registered nurse who reviews clinical content for medical accuracy, ensuring information on 7-OH and kratom dependence, withdrawal, and treatment reflects current evidence-based standards.

References

  1. U.S. FDA — Kratom
  2. DEA — Kratom Drug Fact Sheet
  3. PubMed — 7-OH extraction concentration kratom
  4. Global Wellness Network — 7-OH Public Health Resource

Medical disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions about a medical condition or substance use. If you are experiencing a medical emergency, call 911.

Related Articles

Call 24/7: 1-800-662-4357